Anti-Opioid Peptides

Handbook of Biologically Active Peptides

Volumn , Issue , 2006, Pages 1345-1350

  Wang, John Q ^a   Fibuch, Eugene E ^a   Sakurada, Shinobu ^b   Han, Ji Sheng ^c  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^c PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 49749097778     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369442-3/50190-2     Document Type: Chapter

References (56)

1. Benedetti F. The opposite effects of the opiatc antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain 1996, 64:535-543.
2. Bian JT, Sun MZ, Xu MY, Han JS Antagonism by CCK-8 of the antinociceptive effect of electroacupuncture on painrelated neurons in nucleus parafascicularis of the rat. Asia Pacific J Pharmacol 1993, 8:89-99.
3. Chen L, Huang Y Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by μ-opioids. Neuron 1991, 7:319-326.
4. Devillers JP, Boisserie F, Laulin JP, Larcher A, Simonnet G Simultaneous activation of spinal antiopoid system (neuropeptide FF) and pain facilitatory circuitry by stimulation of opioid receptors in rats. Brain Res 1995, 700:173-181.
5. Ding XZ, Bayer BM Increases of CCK mRNA and peptide in different brain areas following acute and chronic administration of morphine. Brain Res 1993, 625:139-144.
6. Ding XZ, Fan SG, Zhou JP, Han JS Reversal of tolerance to morphine analgesia but not potentiation of morphine-induced analgesia by antiserum against CCK-8. Neuropharmacology 1986, 25:1155-1160.
7. Dupouy V, Zajac JM Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis. Regul Pept 1995, 59:349-356.
8. Dourish CT, O'Neill MF, Coughlan J, Kitchener SJ, Hawley D, Iversen SD The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. Eur J Pharmacol 1990, 176:35-44.
9. 2 (Tyr-W-MIF-1). Peptides 1992, 13:623-631.
10. Faris PL, Komisaruk BR, Watkins LR, Mayer DJ Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science 1983, 219:310-312.
11. Faris PL, McLaughlin CL, Baile CA, Olney JW, Komisaruk BR Morphine analgesia potentiated but tolerance not affected by activc immunization against cholecystokinin. Science 1984, 226:1215-1217.
12. Reference deleted.
13. Gelot A, Frances B, Gicquel S, Zajac JM Antisense oligonucleotides to human SQA-neuropeptide FF decrease morphine tolerance and dependence in mice. Eur J Pharmacol 1998, 358:203-206.
14. Gustafsson H, Lucas GA, Schott E, Stiller CO, Alster P, Wiesenfeld-Hallin Z, Brodin E Peripheral axotomy influences the in vivo release of cholecystokinin in the spinal cord dorsal horn-possible involvement of cholecystokinin-B receptors. Brain Res 1998, 790:141-150.
15. Han JS Cholecystokinin octapeptide (CCK-8): a negative feedback control mechanism for opioid analgesia. Prog Brain Res 1995, 105:263-271.
16. Han JS. Molecular events underlying the anti-opioid effect of cholecytokinin octapeptide (CCK-8) in the central nervous system Pharmacological Sciences: Perspectives for Research and Therapy in the Late 1990s. AC Cuello and B Collier eds Basel, Switzerland: Birkhauser Verlag, pp. 199-207.
17. Han JS, Ding XZ, Fan SG Is cholecystokinin octapeptide a candidate for endogenous antiopioid substance?. Neuropeptides 1985, 5:399-402.
18. Han JS, Terenius L Neurochemical basis of acupuncture analgesia. Ann Rev Pharmacol Toxicol 1982, 22:193-220.
19. Han NL, Luo F, Bian ZP, Han JS Synergistic effect of cholecystokinin ocapeptide and angiotensin II in reversal of morphine induced analgesia in rats. Pain 2000, 85:465-469.
20. Heinricher MM, McGaraughty S, Tortorici V Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla. J Neurophysiol 2001, 85:280-286.
21. Horvath A, Kastin AJ Isolation of tyrosine-melanocytestimulating hormone release-inhibiting factor 1 from bovine brain tissue. J Biol Chem 1989, 264:2175-2179.
22. Kastin AJ, Abel DA, Ehrensing RH, Coy DH, Graf MV Tyr-MIF-1 and MIF-1 are active in the water wheel test for antidepressant drugs. Pharmacol Biochem Behav 1984, 21:767-771.
23. Kastin AJ, Olson RD, Ehrensing RH, Berzas MC, Schally AV, Coy DH MIF-1's differential actions as an opiate antagonist. Pharmacol Biochem Behav 1979, 11:721-723.
24. Kavaliers M. Inhibitory influence of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice. Neurosci Lett 1990, 115:307-312.
25. Kellstein DE, Price DD, Mayer DJ Cholecystokinin and its antagonist lorglumide respectively attenuate and facilitate morphine-induced inhibition of C-fiber evoked discharges of dorsal horn nociceptive neurons. Brain Res 1991, 540:302-306.
26. Lucas GA, Alster P, Brodin E, Wiesenfeld-Hallin Z Differential release of cholecystokinin by morphinc in rat spinal cord. Neurosci Lett 1998, 245:13-16.
27. Magnuson DS, Sullivan AF, Simonnct G, Roques BP, Dickenson AH Differential interactions of cholecystokinin and FLFQPQRF-NH2 with mu and nelta opioid antinociception in the rat spinal cord. Neuropeptides 1990, 16:213-218.
28. Miller KK, Lupica CR Neuropeptide FF inhibition of morphine effects in the rat hippocampus. Brain Res 1997, 750:81-86.
29. Mogil JS, Grisel JE, Zhangs G, Belknap JK, Grandy DK Functional antagonism of mu-, delta-and kappa-opioid antinociception by orphanin FQ. Neurosci Lett 1996, 214:131-134.
30. Morgan MM, Grisel JE, Robbins CS, Grandy DK Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ. Neuroreport 1997, 8:3431-3434.
31. Pu SF, Zhuang HX, Lu ZB, Wu XR, Han JS Cholecystokinin gene expression in rat amygdala neurons: normal distribution and effect of morphine tolerance. Mol Brain Res 1994, 21:183-189.
32. Rady JJ, Fujimoto JM Nociceptin and dynorphin A(1--17) produce antianalgesia through independent systems in mice. Life Sci 2002, 70:1085-1093.
33. Sandrini M, Vitale G, Pini LA, Lopetuso G, Romualdi P, Candeletti S Ociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test. Eur J Pharmacol 2005, 507:43-48.
34. Tang J, Chou J, Iadarola M, Yang HY, Costa E Proglumide prevents and curtails acute tolerance to morphine in rats. Neuropharmacology 1984, 23:715-718.
35. Tang NM, Dong HW, Wang XM, Tsui ZC, Han JS Cholecystokinin antisense RNA increases the analgesic effect induced by electroacupuncture, or low dose morphine: conversion of low responder rats into high responders. Pain 1997, 71:71-80.
36. Tian JH, Xu W, Fang Y, Mogil JS, Grisel JE, Grandy DK, Han JS Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br J Pharmacol 1997, 120:676-680.
37. Tortorici V, Nogueira L, Salas R, Vanegas H Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats. Pain 2003, 102:9-16.
38. Veraksits A, Runkorg K, Kurrikoff K, Raud S, Abramov U, Matsui T, Bourin M, Koks S, Vasar E Altered pain sensitivity and morphine-induced anti-nociception in mice lacking CCK2 receptors. Psychopharmacology 2003, 166:168-175.
39. Verge VMK, Wiesenfeld-Hallin Z, Hokfelt T Cholecystokinin in mammalian primary sensory neurons and spinal cord: in situ hybridization studies in rat and monkey. Eur J Neurosci 1993, 5:240-250.
40. Wang JF, Ren MF, Han JS Mobilization of calcium from intracellular stores is one of the mechanisms underlying the anti-opioid effect of cholecystokinin octapeptide. Peptides 1992, 13:947-951.
41. Wang XJ, Wang XH, Han JS Cholecystokinin octapeptide antagonized opioid analgesia mediated by mu and kappa but not delta receptors in the spinal cord of the rat. Brain Res 1990, 523:5-10.
42. Wang Y, Zhang AX, Xu W, Chang JK, Han JS Orphanin FQ antagonize the analgesic effect of 5-HT in rat brain. Chin Sci Bull 1999, 44:793-795.
43. 2-opioid receptor antagonist in the mouse. J Pharmacol Exp Ther 2005, 312:1075-1081.
44. Watkins LR, Kinscheck IB, Mayer DJ Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide. Science 1984, 224:395-396.
45. Wu HE, Thompson J, Sun HS, Leitermann RJ, Fujimoto JM, Tseng LF Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord. J Pharmacol Exp Ther 2004, 310:240-246.
46. Xu XJ, Hao JX, Seiger A, Hughes J, Hokfelt T, Wiesenfeld-Hallin Z Chronic pain-related behaviors in spinally injured rats: evidence for functional alterations of the endogenous cholecystokinin and opioid systems. Pain 1994, 56:271-277.
47. Xu XJ, Puke MJC, Verge VMK, Wiesenfeld-Hallin Z, Hughes J, Hokfelt T Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain. Neurosci Lett 1993, 152:129-132.
48. Xu XJ, Wiesenfeld-Hallin Z, Hughes J, Horwell DC, Hokfelt T CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat. Br J Pharmacol 1992, 105:591-596.
49. Yehuda S, Kastin AJ, Coy DH Antagonistic actions of MIF-I on the hypothermia and hypomotility induced by betaendorphin or morphine. Int J Neurosci 1980, 11:317-320.
50. Yuan L, Han Z, Chang JK, Han JS Accelerated release and production of orphanin FQ in brain of chronic morphine tolerant rats. Brain Res 1999, 826:330-334.
51. Zadina JE, Kastin AJ, Ge LJ, Hackler L Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent, analogs. Life Sci 1994, 55:PL461-PL466.
52. Zadina JE, Kastin AJ, Kersh D, Wyatt A Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum. Life Sci 1992, 51:869-885.
53. 2+ currents induced by μ-opioid receptors. J Mol Neurosci 2005, 25:21-28.
54. Zhang X, Lucas GA, Elde R, Wiesenfeld-Hallin Z, Hokfelt T Effect of morphine on cholecystokinin and μ-opioid receptor-like immunoreactivities in rat spinal dorsal horn neurons after peripheral axotomy and inflammation. Neuroscience 2000, 95:197-207.
55. B antagonist in ratspinal cord. Neuropeptides 1993, 24:139-144.
56. Zhou Y, Sun YH, Zhang ZW, Han JS Accelerated expression of cholecystokinin gene in the brain of rats rendered tolerant to morphine. Neuroreport 1992, 3:1121-1123.